Showing results (611-620 of 1,032) with videos related to
Sort By:
Pageof 104
JNCI Cancer Spectrum|June 24, 2021
Screening for Depression in Younger Breast Cancer Survivors: Outcomes From Use of the 9-item Patient Health QuestionnairePatricia A Ganz, Julienne E Bower, Ann H Partridge, et al.Psycho-Oncology|March 1, 2019
Identifying distinct trajectories of change in young breast cancer survivors' sexual functioningChristiana von Hippel, Shoshana M Rosenberg, S Bryn Austin, et al.Cancer|April 5, 2023
Effects of an educational physical activity intervention in young women with newly diagnosed breast cancer: Findings from the Young and Strong StudyJennifer A Ligibel, Yue Zheng, William T Barry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2021
Targeting Depressive Symptoms in Younger Breast Cancer Survivors: The Pathways to Wellness Randomized Controlled Trial of Mindfulness Meditation and Survivorship EducationJulienne E Bower, Ann H Partridge, Antonio C Wolff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Ethics of mandatory research biopsy for correlative end points within clinical trials in oncologyJeffrey Peppercorn, Iuliana Shapira, Deborah Collyar, et al.Nature|April 29, 1998
Inhibition of NF-kappaB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesisP B Bushdid, D M Brantley, F E Yull, et al.Biochimica Et Biophysica Acta. Biomembranes|July 21, 2022
Vinca alkaloid binding to P-glycoprotein occurs in a processive mannerShagufta Iqbal, Caitlin Flux, Deborah A Briggs, et al.Nature Communications|February 22, 2024
TcrXY is an acid-sensing two-component transcriptional regulator of Mycobacterium tuberculosis required for persistent infectionMiljan Stupar, Lendl Tan, Edward D Kerr, et al.JAMA Network Open|February 28, 2022
Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast CancerShoshana M Rosenberg, Anne O'Neill, Karen Sepucha, et al.Alimentary Pharmacology & Therapeutics|February 12, 2004
Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational studyJ R B Green, C H J Swan, J A Gibson, et al.Pageof 104